Search Count: 5
 |
Crystal Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) Complexed With Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2019-05-08 Classification: OXIDOREDUCTASE Ligands: NAP, FFW, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-05-08
Ligands: NAP, FFW, EDO
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With 3-Hydroxy-1-Methyl-5-((3-(Trifluoromethyl)Phenoxy)Methyl)-1H-Pyrazole-4-Carboxylic Acid
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, E2N |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2018-12-19
Ligands: FMN, ORO, E2N
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With N-(2,2-Diphenylethyl)-4-Hydroxy-1,2,5-Thiadiazole-3-Carboxamide
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, DZB |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2018-12-19
Ligands: FMN, ORO, DZB
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: NAP, CJ2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: NAP, CJ2
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: CVN, CL, NAP |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: CVN, CL, NAP